ANDA Tagged Articles

Consumer groups, institute team up to urge FDA reform

Posted: January 2, 2009 Pharmaceutical

The National Academies of Sciences Institute of Medicine, the Consumer Federation of America and the Center for Science in the Public Interest have joined together to urge the incoming Obama administration to address food safety issues that have plagued the

Europeans now dependent on China for Panadol, Tylenol

Posted: January 1, 2009 Pharmaceutical

Rhodia SA, a leading producer of paracentamol drugs Panadol and Tylenol, will close its factory in France this week, leaving Europe completely dependent on imports for that drug, according to Bloomberg. Rhodia says it is dropping out of the $800

Tainted heparin may have caused death of infant

Posted: December 23, 2008 Pharmaceutical

An infant may have been among the victims of the tainted heparin scandal earlier this year, according to WorldFocus consultant Peter Eisner, who has reported on the heparin crisis over several months. Eisner reports that Julien, the son of Alex

Quaids get settlement in heparin overdose case

Posted: December 19, 2008 Pharmaceutical

The highly publicized lawsuit between the family of actor Dennis Quaid and Cedars-Sinai Medical Center has been settled, according to The Lowell Sun/Associated Press. Documents show that the Quaids have agreed on a $750,000 settlement with the hospital. The Quaid

Another lawsuit filed in tainted heparin scandal

Posted: December 18, 2008 Pharmaceutical

Another lawsuit has been filed against the Wisconsin-based heparin manufacturer, Scientific Protein Laboratories and one of its major distributors, Baxter International Inc., claiming the companies allowed contaminated batches of heparin to reach hospitals and medical facilities, where it led to

Barton wants answers from FDA about heparin scandal

Posted: December 17, 2008 Pharmaceutical

Rep. Joe Barton, a ranking member of the House Energy and Commerce Committee, appears to be fed up with the FDA’s reluctance to provide details of the tainted heparin scandal that first came into public light earlier this year, according

FDA commissioner announces plans to resign next month

Posted: December 16, 2008 Pharmaceutical

The Associated Press reported today that Food and Drug Administration Commissioner Dr. Andrew von Eschenbach will resign from his post effective Jan. 20, the same day president-elect Barack Obama takes office. Von Eschenbach was appointed by President Bush in 2005

Daschle likely to inherit agency rife with issues

Posted: December 8, 2008 Pharmaceutical

President-elect Barack Obama has made no formal announcement as yet, but it appears likely that Sen. Tom Daschle will be appointed Obama’s choice for Health and Human Services secretary, according to The Federal Times. If so, Dashle will inherit a

Generics may be bio-equivalent of brands, but are they as safe?

Posted: December 5, 2008 Pharmaceutical

Clinical tests conducted by the Journal of the American Medical Association comparing brand and generic cardiovascular drugs show that generic drugs are bio-equivalent to the drugs they are patterned after. And, the FDA adds, generics are far less expensive than

MIT report proves type of contaminant in Chinese heparin

Posted: December 3, 2008 Pharmaceutical

A team of researchers from the Massachusetts Institute of Technology (MIT) has confirmed that over-sulfated chondroitin sulfate was, in fact, the contaminant in heparin that was manufactured in China and triggered serious allergic reactions that caused more than 80 Americans to